Standout Papers
- Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial (2023)
- Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea (2019)
Citation Impact
2 from Science/Nature 65 standout
Citing Papers
Stroke
2024 Standout
Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?
2024 Standout
Works of Srikanth Deenadayalan being referenced
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
2023 Standout
Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea
2019 Standout
Author Peers
| Author | EDM | Molecular Biology | Surgery | Pharmacology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Srikanth Deenadayalan | 448 | 258 | 122 | 148 | 7 | 516 | |
| Earl Nordbrock | 4 | 8 | 223 | 41 | 18 | 768 | |
| Clairice Cooper | 137 | 8 | 14 | 314 | |||
| C Schaldach | 21 | 292 | 17 | 52 | 13 | 665 | |
| Ewelina Król | 93 | 185 | 19 | 26 | 36 | 642 | |
| Samir S. Patel | 1315 | 1 | 8 | 1.4k |
All Works
Loading papers...